73 related articles for article (PubMed ID: 11245438)
21. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
[TBL] [Abstract][Full Text] [Related]
22. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
[TBL] [Abstract][Full Text] [Related]
23. Fas-1377 A/G polymorphism in lung cancer.
Gormus U; Ergen A; Yaylim-Eraltan I; Yilmaz H; Turna A; Bozkurt N; Isbir T
In Vivo; 2007; 21(4):663-6. PubMed ID: 17708363
[TBL] [Abstract][Full Text] [Related]
24. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
[TBL] [Abstract][Full Text] [Related]
25. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
26. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome.
Tighe PJ; Stevens SE; Dempsey S; Le Deist F; Rieux-Laucat F; Edgar JD
Genes Immun; 2002 Oct; 3 Suppl 1():S66-70. PubMed ID: 12215906
[TBL] [Abstract][Full Text] [Related]
28. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.
Bariş YS; Yildiz L; Sentürk N; Kandemir B
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710
[TBL] [Abstract][Full Text] [Related]
29. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH
Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509
[TBL] [Abstract][Full Text] [Related]
30. The role of apoptosis in thyroid disease.
Tsatsoulis A
Minerva Med; 2002 Jun; 93(3):169-80. PubMed ID: 12094148
[TBL] [Abstract][Full Text] [Related]
31. Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells.
Tourneur L; Mistou S; Michiels FM; Devauchelle V; Renia L; Feunteun J; Chiocchia G
Oncogene; 2003 May; 22(18):2795-804. PubMed ID: 12743602
[TBL] [Abstract][Full Text] [Related]
32. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
[TBL] [Abstract][Full Text] [Related]
33. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
34. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.
Grønbaek K; Straten PT; Ralfkiaer E; Ahrenkiel V; Andersen MK; Hansen NE; Zeuthen J; Hou-Jensen K; Guldberg P
Blood; 1998 Nov; 92(9):3018-24. PubMed ID: 9787134
[TBL] [Abstract][Full Text] [Related]
35. Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma.
Lee SH; Shin MS; Kim HS; Lee HK; Park WS; Kim SY; Lee JH; Han SY; Park JY; Oh RR; Kang CS; Kim KM; Jang JJ; Nam SW; Lee JY; Yoo NJ
Oncogene; 2001 Jan; 20(3):399-403. PubMed ID: 11313970
[TBL] [Abstract][Full Text] [Related]
36. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis.
Müllauer L; Emhofer J; Wohlfart S; Pichlhöfer B; Stary S; Ebetsberger G; Mannhalter C; Chott A
Am J Surg Pathol; 2008 Feb; 32(2):329-34. PubMed ID: 18223337
[TBL] [Abstract][Full Text] [Related]
38. Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome.
MacLean HE; Ball EM; Rekaris G; Warne GL; Zajac JD
Hum Mutat; 2004 Mar; 23(3):287. PubMed ID: 14974091
[TBL] [Abstract][Full Text] [Related]
39. Fas and Fas ligand gene mutations in Hashimoto's thyroiditis.
Dong Z; Takakuwa T; Takayama H; Luo WJ; Takano T; Amino N; Matsuzuka F; Aozasa K
Lab Invest; 2002 Dec; 82(12):1611-6. PubMed ID: 12480911
[TBL] [Abstract][Full Text] [Related]
40. A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening.
Kaldrymides P; Mytakidis N; Anagnostopoulos T; Vassiliou M; Tertipi A; Zahariou M; Rampias T; Koutsodontis G; Konstantopoulou I; Ladopoulou A; Bei T; Yannoukakos D
Clin Endocrinol (Oxf); 2006 May; 64(5):561-6. PubMed ID: 16649977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]